Upgrade to SI Premium - Free Trial

Pre-Open Stock Movers 12/04: (KBIO) (AVP) (FIVE) Higher; (ZUMZ) (BKS) (COO) Lower (more...)

December 4, 2015 9:26 AM
KaloBios Pharma (NASDAQ: KBIO) 18.6% HIGHER; announced that it has signed an agreement to acquire a benznidazole program for the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Special Reports

Next Articles